Regulated trafficking of APP by SORLA in Alzheimer’s disease

Proteolytic breakdown of the amyloid precursor protein (APP) by secretases is a complex cellular process that results in formation of neurotoxic Aβ peptides, causative of neurodegeneration in Alzheimer’s disease (AD). Processing involves monomeric and dimeric forms of APP that traffic through distin...

Full description

Saved in:
Bibliographic Details
Main Author: Lao, Angelyn R.
Format: text
Published: Animo Repository 2012
Subjects:
Online Access:https://animorepository.dlsu.edu.ph/faculty_research/7448
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: De La Salle University
Description
Summary:Proteolytic breakdown of the amyloid precursor protein (APP) by secretases is a complex cellular process that results in formation of neurotoxic Aβ peptides, causative of neurodegeneration in Alzheimer’s disease (AD). Processing involves monomeric and dimeric forms of APP that traffic through distinct cellular compartments where the various secretases reside. Amyloidogenic processing is also influenced by modifiers such as sorting receptor-related protein (SORLA), an inhibitor of APP breakdown and major AD risk factor. This study aims to (i) model the neuronal factors central to the proteolytic processing of amyloid precursor protein (APP),(ii) trace the trafficking of APP in various compartments, and (iii) evaluate the influence of the SORLA on those factors. Using experimental data and literature-based, information we developed a multi-compartment model to simulate the complexity of APP processing in neurons, and to accurately describe the effects of SORLA on these processes. Our model enables regulation of trafficking of APP by SORLA through intracellular compartments. We have successfully confirmed our hypothesis that blockade of APP dimerization is an important aspect of SORLA action on AD. Using this model, we are able to uncover that SORLA not only affects amyloidogenic processing through interaction with APP but also specifically targets β-secretase-the enzyme responsible for initial amyloidogenic cleavage. Our model represents a major conceptual advancement by identifying APP dimers and β-secretase as the two distinct targets of the inhibitory action of SORLA in AD.